Investigating of Anti-Diabetic Potential of Secondary Metabolites from Abies Webbiana
Abstract
Abies Webbiana, commonly known as the Himalayan silver fir, is a coniferous tree native to the Himalayan region and has been traditionally used in folk medicine. This study aimed to isolate and characterize secondary metabolites from Abies Webbiana and evaluate their pharmacological activities.
The secondary metabolites were extracted using various solvent systems and then isolated using chromatographic techniques. The isolated compounds were characterized using spectroscopic methods such as nuclear magnetic resonance (NMR) and mass spectrometry (MS).
Our results revealed the successful isolation and characterization of several secondary metabolites from Abies Webbiana, including terpenoids, flavonoids, and phenolic compounds. These compounds exhibited promising pharmacological activities, including significant antioxidant and anti-inflammatory effects.
This study highlights the pharmaceutical potential of Abies Webbiana as a source of bioactive compounds with diverse pharmacological activities. Further research is warranted to elucidate the mechanisms of action and therapeutic potential of these isolated secondary metabolites for the development of novel pharmacotherapeutic agents.
References
2. WHO. Diabetes. 2024 [cited 2024 2024]; Available from: https://www.who.int/health-topics/diabetes#tab=tab_1.
3. WHO. Mean fasting blood glucose. 2024 [cited 2024 april 2024]; Available from: https://www.who.int/data/gho/indicator-metadata-registry/imr-details/2380#:~:text=The%20expected%20values%20for%20normal,(5.6%20mmol%2FL).
4. Zimmet, P.Z., et al., Diabetes: a 21st century challenge. Lancet Diabetes Endocrinol, 2014. 2(1): p. 56-64.
5. Baumann, C.A., et al., CAP defines a second signalling pathway required for insulin-stimulated glucose transport. Nature, 2000. 407(6801): p. 202-207.
6. Chiang, S.-H., et al., Insulin-stimulated GLUT4 translocation requires the CAP-dependent activation of TC10. Nature, 2001. 410(6831): p. 944-948.
7. Lock, L.S., et al., Identification of an atypical Grb2 carboxyl-terminal SH3 domain binding site in Gab docking proteins reveals Grb2-dependent and-independent recruitment of Gab1 to receptor tyrosine kinases. Journal of Biological Chemistry, 2000. 275(40): p. 31536-31545.
8. Noguchi, T., et al., Tyrosine phosphorylation of p62Dok induced by cell adhesion and insulin: possible role in cell migration. The EMBO journal, 1999.
9. Pawson, T. and J.D. Scott, Signaling through scaffold, anchoring, and adaptor proteins. Science, 1997. 278(5346): p. 2075-2080.
10. Previs, S.F., et al., Contrasting effects of IRS-1 versus IRS-2 gene disruption on carbohydrate and lipid metabolism in vivo. Journal of Biological Chemistry, 2000. 275(50): p. 38990-38994.
11. Rui, L., et al., Regulation of insulin/insulin-like growth factor-1 signaling by proteasome-mediated degradation of insulin receptor substrate-2. Journal of Biological Chemistry, 2001. 276(43): p. 40362-40367.
12. White, M.F., IRS proteins and the common path to diabetes. American Journal of Physiology-Endocrinology and Metabolism, 2002. 283(3): p. E413-E422.
13. Whitehead, J.P., et al., Molecular scanning of the insulin receptor substrate 1 gene in subjects with severe insulin resistance: detection and functional analysis of a naturally occurring mutation in a YMXM motif. Diabetes, 1998. 47(5): p. 837-839.
14. Yamauchi, T., et al., Insulin signalling and insulin actions in the muscles and livers of insulin-resistant, insulin receptor substrate 1-deficient mice. Molecular and cellular biology, 1996. 16(6): p. 3074-3084.
15. Alessi, D.R. and P. Cohen, Mechanism of activation and function of protein kinase B. Current opinion in genetics & development, 1998. 8(1): p. 55-62.
16. Kotani, K., et al., Requirement of atypical protein kinase Cλ for insulin stimulation of glucose uptake but not for Akt activation in 3T3-L1 adipocytes. Molecular and cellular biology, 1998. 18(12): p. 6971-6982.
